Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lodge

Showing results (81-90 of 135) with videos related to

Pageof 14
Sort By:
Pharmacology, Biochemistry, and Behavior|January 1, 1986
2-Methyl-3,3-diphenyl-3-propanolamine (2-MDP) selectively antagonises N-methyl-aspartate (NMA)J C Blake, S N Davies, J Church, et al.
British Journal of Pharmacology|October 1, 1988
Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitroE J Fletcher, D Martin, J A Aram, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 26, 1999
Group II selective metabotropic glutamate receptor agonists and local cerebral glucose use in the ratA G Lam, J A Monn, D D Schoepp, et al.
Neuroreport|May 28, 1998
Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemiaA Bond, M J O'Neill, C A Hicks, et al.
European Journal of Pharmacology|October 8, 1999
NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampusA Bond, D Lodge, C A Hicks, et al.
Neuropharmacology|January 1, 1996
Stereoselective effects-of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studiesD Lodge, A Bond, M J O'Neill, et al.
Neurochemical Research|October 5, 2018
The 1980s: D-AP5, LTP and a Decade of NMDA Receptor DiscoveriesD Lodge, J C Watkins, Z A Bortolotto, et al.
Experimental Brain Research|January 1, 1982
The dual effects of GABA and related amino acids on the electrical threshold of ventral horn group Ia afferent terminations in the catD R Curtis, D Lodge, J C Bornstein, et al.
Experimental Brain Research|December 22, 1976
The sensitivity of rat spinal interneurones and renshaw cells to L-glutamate and L-aspartateT J Biscoe, P M Headley, D Lodge, et al.
British Journal of Pharmacology|March 6, 2002
Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivoE F Sharpe, A E Kingston, D Lodge, et al.
Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
Pharmacology, Biochemistry, and Behavior|January 1, 1986
2-Methyl-3,3-diphenyl-3-propanolamine (2-MDP) selectively antagonises N-methyl-aspartate (NMA)J C Blake, S N Davies, J Church, et al.
British Journal of Pharmacology|October 1, 1988
Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitroE J Fletcher, D Martin, J A Aram, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 26, 1999
Group II selective metabotropic glutamate receptor agonists and local cerebral glucose use in the ratA G Lam, J A Monn, D D Schoepp, et al.
Neuroreport|May 28, 1998
Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemiaA Bond, M J O'Neill, C A Hicks, et al.
European Journal of Pharmacology|October 8, 1999
NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampusA Bond, D Lodge, C A Hicks, et al.
Neuropharmacology|January 1, 1996
Stereoselective effects-of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studiesD Lodge, A Bond, M J O'Neill, et al.
Neurochemical Research|October 5, 2018
The 1980s: D-AP5, LTP and a Decade of NMDA Receptor DiscoveriesD Lodge, J C Watkins, Z A Bortolotto, et al.
Experimental Brain Research|January 1, 1982
The dual effects of GABA and related amino acids on the electrical threshold of ventral horn group Ia afferent terminations in the catD R Curtis, D Lodge, J C Bornstein, et al.
Experimental Brain Research|December 22, 1976
The sensitivity of rat spinal interneurones and renshaw cells to L-glutamate and L-aspartateT J Biscoe, P M Headley, D Lodge, et al.
British Journal of Pharmacology|March 6, 2002
Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivoE F Sharpe, A E Kingston, D Lodge, et al.
Pageof 14